McKesson Corporation (N:MCK)

Aug 14, 2020 01:59 pm ET
McKesson to Distribute Future COVID-19 Vaccines in Support of Operation Warp Speed
A global leader in the healthcare industry, McKesson Corporation (NYSE: MCK) will expand its existing partnership with the Centers for Disease Control (CDC) to support the U.S. government’s Operation Warp Speed (OWS) team as a centralized distributor of future COVID-19 vaccines and ancillary supplies needed to administer vaccinations. Vaccines and related supplies will be delivered to point-of-care sites across the country at the U.S. government’s direction.
Aug 03, 2020 07:00 am ET
McKesson Reports Fiscal 2021 First-Quarter Results
McKesson Corporation (NYSE:MCK) today reported results for the first quarter ended June 30, 2020.
Jul 29, 2020 04:27 pm ET
McKesson Declares Quarterly Dividend July 29, 2020
The Board of Directors of McKesson Corporation (NYSE:MCK) today declared a regular dividend of 42 cents per share of common stock. The dividend will be payable on October 1, 2020, to stockholders of record on September 1, 2020.
Jul 06, 2020 04:10 pm ET
McKesson Corporation to Announce First Quarter Fiscal 2021 Results on August 3, 2020
McKesson Corporation (NYSE:MCK) will release its first quarter fiscal 2021 financial results before market open on Monday, August 3, 2020. The company will host a live webcast of the earnings conference call for investors at 8:00 AM Eastern Time to review its financial results.
Jul 01, 2020 04:10 pm ET
McKesson Realigns Organizational Structure to Better Serve Customers and Patients While Optimizing Growth
McKesson Corporation (NYSE:MCK) today announces changes to its reportable business structure. The Company has revised its reportable segments commencing in the second quarter of fiscal 2021.
Jun 04, 2020 04:15 pm ET
McKesson Appoints Tom Rodgers to Executive Vice President & Chief Strategy and Business Development Officer
McKesson Corporation (NYSE:MCK) today announced Tom Rodgers has been appointed executive vice president and chief strategy and business development officer effective June 5, 2020. In his new role, Rodgers will also become a member of the company’s Executive Operating Team. Rodgers succeeds Bansi Nagji who stepped down from his role effective March 31, 2020.
May 20, 2020 07:00 am ET
McKesson Reports Fiscal 2020 Fourth-Quarter and Full-Year Results
McKesson Corporation (NYSE:MCK) today reported results for the fourth quarter and fiscal year ended March 31, 2020.
Apr 29, 2020 04:10 pm ET
McKesson Declares Quarterly Dividend April 29, 2020
The Board of Directors of McKesson Corporation (NYSE:MCK) today declared a regular dividend of 41 cents per share of common stock. The dividend will be payable on July 1, 2020, to stockholders of record on June 1, 2020.
Apr 20, 2020 04:10 pm ET
McKesson Corporation to Announce Fourth Quarter Fiscal 2020 Results on May 20, 2020
McKesson Corporation (NYSE:MCK) will release its fourth quarter fiscal 2020 financial results before market open on Wednesday, May 20, 2020. The company will host a conference call for investors at 8:00 AM Eastern Time to review its financial results.
Mar 23, 2020 04:46 pm ET
McKesson Announces Bansi Nagji to Step Down as Executive Vice President, Chief Strategy and Business Development Officer
McKesson Corporation (NYSE:MCK) today announced that Bansi Nagji, executive vice president and chief strategy and business development officer, will step down from his role effective March 31, 2020. Mr. Nagji has agreed to continue employment with the company for several weeks to assist with transition activities. McKesson is currently conducting a comprehensive search and expects to name Nagji’s successor within the next few months.
Mar 17, 2020 04:10 pm ET
McKesson Updates Fiscal 2020 Guidance Following Completion of Change Healthcare Split-Off
McKesson Corporation (NYSE:MCK) today announced it is updating its adjusted earnings outlook for the fiscal year ending March 31, 2020 to reflect the completion of the company’s exit of its investment in Change Healthcare, as announced on March 10, 2020.
Mar 12, 2020 08:00 am ET
McKesson Announces Final Results of Exchange Offer
McKesson Corporation (NYSE:MCK) today announced the final results of its offer to its stockholders to exchange their issued and outstanding shares of McKesson common stock for shares of PF2 SpinCo, Inc. (“SpinCo”) common stock owned by McKesson as part of its split-off of its interest in Change Healthcare LLC (“Change Healthcare”) and its agreement with Change Healthcare Inc. (NASDAQ:CHNG) (“Change”) to merge SpinCo with and into Change.
Mar 10, 2020 09:00 am ET
McKesson Completes Split-off of Its Interest in Change Healthcare
McKesson Corporation (NYSE:MCK) today announced the completion of the split-off of PF2 SpinCo, Inc. (“SpinCo”), which held McKesson’s interest in Change Healthcare LLC (“Change Healthcare”) and which was merged with and into Change Healthcare Inc. (NASDAQ:CHNG) (“Change”) through a “Reverse Morris Trust” transaction. The closing of the merger followed the previously announced expiration of McKesson’s exchange offer. As a result of the merger, participating McKesson stockholders will receive one share of Change common stock in exchange for each whole share of SpinCo common stock they received i
Mar 10, 2020 08:00 am ET
McKesson Announces Preliminary Results of Exchange Offer
McKesson Corporation (NYSE:MCK) today announced that its previously announced offer to stockholders to exchange their shares of McKesson common stock on a per-share-basis for 11.4086 shares of PF2 SpinCo, Inc. (“SpinCo”) common stock expired at 11:59 p.m., New York City time, on March 9, 2020, and, based on preliminary results, the exchange offer was oversubscribed. The exchange offer to split-off SpinCo, which holds McKesson’s interest in Change Healthcare LLC (“Change Healthcare”), is part of McKesson’s agreement with Change Healthcare Inc. (NASDAQ:CHNG) (“Change”) to merge SpinCo with and i
Mar 05, 2020 05:50 pm ET
McKesson Sets Final Exchange Ratio of 11.4086 for Exchange Offer
McKesson Corporation (NYSE:MCK) today announced the final exchange ratio of 11.4086-for-one in connection with its previously announced offer to its stockholders to exchange their shares of McKesson common stock for shares of PF2 SpinCo, Inc. (“SpinCo”) common stock. The exchange offer to split-off SpinCo, which holds McKesson’s interest in Change Healthcare LLC (“Change Healthcare”), is part of McKesson’s agreement with Change Healthcare Inc. (NASDAQ:CHNG) (“Change”) to merge SpinCo with and into Change.
Feb 10, 2020 07:31 am ET
McKesson Launches Exchange Offer to Split-Off Its Interest in Change Healthcare
McKesson Corporation (NYSE:MCK) today announced the commencement of an exchange offer for the split-off of its wholly-owned subsidiary, PF2 SpinCo, Inc. (“SpinCo”), which will hold all of McKesson’s interest in Change Healthcare LLC (“Change Healthcare”), as part of McKesson’s previously announced agreement with Change Healthcare Inc. (Nasdaq:CHNG) (“Change”) to merge SpinCo with and into Change.
Feb 04, 2020 07:00 am ET
McKesson Reports Fiscal 2020 Third Quarter Results
McKesson Corporation (NYSE:MCK) today reported results for the third quarter ended December 31, 2019.
Jan 29, 2020 04:10 pm ET
McKesson Declares Quarterly Dividend
The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 41 cents per share of common stock. The dividend will be payable on April 1, 2020, to stockholders of record on March 2, 2020.
Jan 13, 2020 04:10 pm ET
McKesson to Present at the 38th Annual J.P. Morgan Healthcare Conference: Will Provide Company Overview and Review Updated Financial Outlook
McKesson Corporation (NYSE:MCK) will present at the 38th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco tomorrow, January 14, 2020 at 9:00 AM PT (12:00 PM ET). Brian Tyler, chief executive officer of McKesson, will provide a company overview and review topics including:
Jan 03, 2020 09:00 am ET
McKesson Corporation to Announce Third Quarter Fiscal 2020 Results on February 4, 2020
McKesson Corporation (NYSE:MCK) announced today that its third quarter fiscal 2020 financial results will be released before market open on Tuesday, February 4, 2020. The company will host a conference call at 8:00 AM Eastern Time to discuss the financial results.
Dec 18, 2019 08:30 am ET
McKesson Reaffirms Fiscal 2020 Guidance
McKesson Corporation (NYSE:MCK) today reaffirmed its Adjusted Earnings per diluted share guidance of $14.00 to $14.60 for the fiscal year ending March 31, 2020.
Dec 12, 2019 11:01 am ET
McKesson Selected by Department of Veterans Affairs as Prime Pharmaceutical Provider
McKesson Corporation (NYSE: MCK) announced today that it has been selected by the Department of Veterans Affairs (VA), which runs the nation’s largest integrated healthcare system, to continue as the prime pharmaceutical supplier for the agency. Under the new agreement, which takes effect in Aug. 2020, McKesson will supply all of the VA's medical centers and outpatient clinics, as well as the VA's Consolidated Mail Outpatient Pharmacies (CMOPs). The initial two-year contract includes options for up to three, two-year extensions.
Dec 12, 2019 04:00 am ET
Walgreens Boots Alliance and McKesson to Create German Wholesale Joint Venture
Walgreens Boots Alliance (Nasdaq: WBA) and McKesson Corporation (NYSE: MCK) today signed an agreement to create a joint venture that will combine their respective pharmaceutical wholesale businesses in Germany, Alliance Healthcare Deutschland and GEHE Pharma Handel. WBA will have a 70% controlling equity interest in the joint venture and McKesson will have a 30% ownership interest.
Dec 10, 2019 04:10 pm ET
McKesson to Host Sell-Side Analyst Meeting on December 18, 2019
McKesson Corporation (NYSE: MCK) announced today it will host a sell-side analyst meeting on Wednesday, December 18, 2019 at its corporate headquarters in Irving, Texas. During the meeting, CEO Brian Tyler and CFO Britt Vitalone will provide a general business update.
Dec 09, 2019 04:10 pm ET
McKesson Appoints Nancy Flores as Executive Vice President, Chief Information and Chief Technology Officer
McKesson Corporation (NYSE:MCK) today announced that Nancy Flores will join McKesson as its new executive vice president, chief information officer (CIO) and chief technology officer (CTO) on Jan. 13, 2020, succeeding Kathy McElligott who announced her retirement earlier this year. Flores currently serves as CIO for Johnson Controls, where she is responsible for Global Business Services, which includes back office shared services, information technology, cybersecurity and analytics.
Nov 14, 2019 08:33 pm ET
Bragar Eagel & Squire is Investigating Certain Officers and Directors of Meredith Corporation, McKesson Corporation, Maxar Technologies, and ViewRay and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, is investigating certain officers and directors of Meredith Corporation (NYSE: MDP), McKesson Corporation (NYSE: MCK), Maxar Technologies, Inc. (NYSE: MAXR), and ViewRay,...
Nov 08, 2019 10:59 pm ET
McKesson (MCK) Alert: Johnson Fistel Announces Shareholder Class Action Against McKesson Corporation Survives Motion to Dismiss; Should Management be Held Accountable for Investors Losses?
SAN DIEGO, Nov. 8, 2019 /PRNewswire/ -- Johnson Fistel, LLP is investigating potential claims on behalf of McKesson Corporation (NYSE: MCK) ("McKesson" or the "Company") against certain of its officers and directors. ...
Oct 30, 2019 07:00 am ET
McKesson Reports Fiscal 2020 Second-Quarter Results
McKesson Corporation (NYSE:MCK) today reported results for the second quarter ended September 30, 2019.
Oct 23, 2019 04:10 pm ET
McKesson Declares Quarterly Dividend October 23, 2019
The Board of Directors of McKesson Corporation (NYSE:MCK) today declared a regular dividend of 41 cents per share of common stock. The dividend will be payable on January 2, 2020, to stockholders of record on December 2, 2019.
Oct 21, 2019 11:38 am ET
Distributors Reach Settlement With Ohio Counties in Opioids Case
AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced this morning that they have agreed to a $215 million settlement with two Ohio counties, Cuyahoga and Summit, in the first track of the multi-district opioid litigation. With this settlement agreed upon, the companies and the other parties will now continue the work toward a global resolution.
Sep 30, 2019 04:10 pm ET
McKesson Corporation to Announce Second Quarter Fiscal 2020 Results on October 30, 2019
McKesson Corporation (NYSE:MCK) announced today that its second quarter fiscal 2020 financial results will be released before market open on Wednesday, October 30, 2019. The company will host a conference call at 8:00 AM Eastern Time to discuss the financial results.
Jul 31, 2019 04:10 pm ET
McKesson Reports Fiscal 2020 First-Quarter Results
McKesson Corporation (NYSE:MCK) today reported that revenues for the first quarter ended June 30, 2019, were $55.7 billion compared to $52.6 billion a year ago, an increase of 6% on a reported basis and an increase of 7% on an FX-adjusted basis.
Jun 27, 2019 04:12 pm ET
McKesson Corporation to Announce First Quarter Fiscal 2020 Results on July 31, 2019
McKesson Corporation (NYSE:MCK) announced today that its first quarter fiscal 2020 financial results will be released on Wednesday, July 31, 2019 following the close of market. The company will host a conference call at 5:00 PM Eastern Time (2:00 PM Pacific Time) the same day to discuss the financial results. During this call, the company will also provide an update on fiscal 2020 outlook assumptions following the completion of the Change Healthcare initial public offering.
Jun 27, 2019 04:10 pm ET
McKesson Issues Statement on Change Healthcare IPO
McKesson Corporation (NYSE:MCK) offers the below statement on today’s Change Healthcare initial public offering:
Jun 17, 2019 04:10 pm ET
McKesson’s Board of Directors Elects Dr. Ken Washington as New Independent Director
McKesson Corporation (NYSE:MCK) today announced that its board of directors elected Dr. Ken Washington as a new independent director, effective July 1, 2019. With the election of Dr. Washington, McKesson’s board of directors increases from nine to ten members, nine of whom are independent.
May 08, 2019 05:25 pm ET
CORRECTING and REPLACING McKesson Reports Fiscal 2019 Fourth-Quarter and Full-Year Results
Schedule 5, Condensed Consolidated Statements of Cash Flows is corrected to include the line “Gain from Sale of Businesses and Investments” and the corresponding amounts for the years ended March 31, 2018 and 2019. This correction does not impact net cash provided by operating activities as previously presented for either period.
May 02, 2019 12:15 pm ET
McKesson Reaches Settlement With State of West Virginia on Opioid Order Monitoring and Reporting
McKesson Corporation (NYSE:MCK) today announced that it has settled litigation with the State of West Virginia to resolve all claims regarding McKesson’s operations in the state.
Apr 26, 2019 04:31 pm ET
McKesson Appoints Tracy Faber to Top HR Role
McKesson Corporation (NYSE:MCK) today announced that Tracy Faber has been appointed executive vice president and chief human resources officer (CHRO), effective October 1, 2019. Faber will report to CEO Brian Tyler.
Apr 24, 2019 04:10 pm ET
McKesson Declares Quarterly Dividend April 24, 2019
The Board of Directors of McKesson Corporation (NYSE:MCK) today declared a regular dividend of thirty-nine cents per share on Common Stock. The dividend will be payable on July 1, 2019, to stockholders of record on June 3, 2019.
Apr 15, 2019 04:30 pm ET
Kirk Kaminsky to Lead McKesson’s U.S.-Based Pharmaceutical Business
McKesson Corporation (NYSE:MCK) today announced that Kirk Kaminsky will be the new president of McKesson’s U.S. Pharmaceutical and Specialty Solutions (USPSS) business. Kaminsky will assume the role effective immediately, reporting to CEO Brian Tyler.
Apr 10, 2019 04:10 pm ET
McKesson Corporation to Hold Fiscal 2019 Fourth Quarter Conference Call and Participate in the Bank of America Merrill Lynch Health Care Conference
McKesson Corporation (NYSE:MCK) will release financial results for its fourth quarter ended March 31, 2019 on Wednesday, May 8, 2019, prior to the opening of trading on the New York Stock Exchange. The company has scheduled a conference call for 8:00 AM Eastern Time (5:00 AM Pacific Time), during which Brian Tyler, chief executive officer, and Britt Vitalone, executive vice president and chief financial officer, will review these results.
Feb 08, 2019 08:10 am ET
Recent Analysis Shows Amerco, McKesson, Ophthotech, IQVIA, Highwoods Properties, and ABM Industries Market Influences — Renewed Outlook, Key Drivers of Growth
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Amerco (NASDAQ:UHAL), McKesson Corporation (NYSE:MCK), Ophthotech...
Jan 31, 2019 04:10 pm ET
McKesson Reports Fiscal 2019 Third-Quarter Results
McKesson Corporation (NYSE:MCK) today reported that revenues for the third quarter ended December 31, 2018, were $56.2 billion, up 5% compared to $53.6 billion a year ago, and also up 5% on a constant currency basis. On the basis of U.S. generally accepted accounting principles (“GAAP”), third-quarter earnings per diluted share from continuing operations was $2.41, compared to earnings per diluted share of $4.32 a year ago. Prior year GAAP earnings per diluted share included a net tax benefit of approximately $1.78 per diluted share driven by th
Jan 07, 2019 04:15 pm ET
McKesson Corporation Fiscal 2019 Third Quarter Conference Call Scheduled for January 31, 2019
McKesson Corporation (NYSE:MCK) will release financial results for its third fiscal quarter ended December 31, 2018 on Thursday, January 31, 2019, following the market close at approximately 4:00 PM Eastern Time (1:00 PM Pacific Time). The company has scheduled a conference call for 5:00 PM Eastern Time (2:00 PM Pacific Time), during which John Hammergren, chairman and chief executive officer, Brian Tyler, president and chief operating officer, and Britt Vitalone, executive vice president and chief financial officer, will review these results.
Jan 07, 2019 08:30 am ET
McKesson and Genpact Expand Their Relationship to Support McKesson’s Finance Operating Model Optimization
McKesson (NYSE:MCK), a leader in healthcare supply chain management solutions and healthcare information technology, and Genpact (NYSE:G), a global professional services firm focused on delivering process transformation, today announced the expansion of their relationship that will advance McKesson’s finance operating model and cost structu
Dec 26, 2018 10:00 am ET
FINAL DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against McKesson Corporation (MCK) & Lead Plaintiff Deadline -December 26, 2018
Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against McKesson Corporation (“McKesson” or the “Company”) (NYSE: MCK) on behalf of shareholders who purchased or otherwise...
Dec 26, 2018 08:40 am ET
DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against McKesson Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against McKesson Corporation (“McKesson” or “the Company”) (NYSE: MCK) for violations of §§10(b) and 20(a) of the Securities Exchange...
Dec 24, 2018 10:26 am ET
MCK EQUITY NOTICE: Rosen Law Announces Filings of Securities Class Action Against McKesson Corporation; Important Dec. 26 Deadline - MCK
NEW YORK, Dec. 24, 2018 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of McKesson Corporation (NYSE: MCK) from October 24, 2013 through January 25, 2017, inclusive (the "Class Period") of the important December 26, 2018 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for McKesson investors under the federal securities laws....
Dec 24, 2018 08:55 am ET
WEDNESDAY DEADLINE REMINDER: The Schall Law Firm Announces it is Investigating Claims Against McKesson Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of McKesson Corporation (“McKesson” or “the Company”) (NYSE:
Dec 21, 2018 05:44 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of McKesson Corporation - MCK
Pomerantz LLP is investigating claims on behalf of investors of McKesson Corporation (“McKesson” or the “Company”) (NYSE: MCK).  Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980....
Dec 21, 2018 12:00 pm ET
WEDNESDAY DEADLINE The Schall Law Firm Announces it is Investigating Claims Against McKesson Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of McKesson Corporation (“McKesson” or “the Company”) (NYSE:
Dec 20, 2018 03:57 pm ET
DECEMBER 26 DEADLINE: Rosen Law Firm Reminds McKesson Corporation Investors of Important Deadline in Class Action – MCK
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of McKesson Corporation (NYSE: MCK) from October 24, 2013 through January 25, 2017, inclusive (the “Class...
Dec 20, 2018 10:00 am ET
SHAREHOLDER ALERT -- Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against McKesson Corporation (MCK) & Lead Plaintiff Deadline -December 26, 2018
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against McKesson Corporation (“McKesson” or the “Company”) (NYSE: MCK) on behalf of shareholders who purchased or otherwise...
Dec 17, 2018 01:53 pm ET
Deadline Alert: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against McKesson Corporation
Law Offices of Howard G. Smith reminds investors of the December 18, 2018 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased McKesson Corporation (“McKesson” or the “Company”) (NYSE: MCK)...
Dec 17, 2018 11:40 am ET
DEADLINE NEXT WEEK: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against McKesson Corporation and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against McKesson Corporation (“McKesson” or “the Company”) (NYSE: MCK) for violations of §§10(b) and 20(a) of the Securities Exchange...
Dec 14, 2018 05:55 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of McKesson Corporation - MCK
Pomerantz LLP is investigating claims on behalf of investors of McKesson Corporation (“McKesson” or the “Company”) (NYSE: MCK).  Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980....
Dec 11, 2018 12:33 pm ET
Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against McKesson Corporation
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the December 26, 2018 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased McKesson Corporation (“McKesson” or the “Company”) (NYSE:...
Dec 11, 2018 10:00 am ET
SHAREHOLDER ALERT -- Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against McKesson Corporation (MCK) and Lead Plaintiff Deadline -December 26, 2018
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against McKesson Corporation (“McKesson” or the “Company”) (NYSE: MCK) on behalf of shareholders who purchased or otherwise...
Dec 10, 2018 03:30 pm ET
UPCOMING DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against McKesson Corporation and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against McKesson Corporation (“McKesson” or “the Company”) (NYSE: MCK) for violations of §§10(b) and 20(a) of the Securities Exchange...
Dec 07, 2018 04:52 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of McKesson Corporation - MCK
Pomerantz LLP is investigating claims on behalf of investors of McKesson Corporation (“McKesson” or the “Company”) (NYSE: MCK).   Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980. The...
Dec 07, 2018 07:50 am ET
Consolidated Research: 2018 Summary Expectations for Equifax, Celanese, McKesson, ManpowerGroup, NewMarket, and Phillips 66 — Fundamental Analysis, Key Performance Indications
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Equifax, Inc. (NYSE:EFX), Celanese Corporation (NYSE:CE), McKesson...
Dec 05, 2018 10:00 am ET
SHAREHOLDER ALERT -- Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against McKesson Corporation (MCK) and Lead Plaintiff Deadline -December 26, 2018
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against McKesson Corporation (“McKesson” or the “Company”) (NYSE: MCK) on behalf of shareholders who purchased or otherwise...
Dec 04, 2018 06:05 pm ET
Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against McKesson Corporation
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the December 26, 2018 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased McKesson Corporation (“McKesson” or the “Company”) (NYSE:
Dec 03, 2018 03:21 pm ET
Deadline Alert: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against McKesson Corporation
Law Offices of Howard G. Smith reminds investors of the December 18, 2018 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased McKesson Corporation (“McKesson” or the “Company”) (NYSE: MCK) securities between October 24, 2013 and January 25, 2017, inclus
Dec 03, 2018 02:51 pm ET
INVESTOR NOTICE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against McKesson Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against McKesson Corporation (“McKesson” or “the Company”) (NYSE: MCK) for violations of §§10(b) and 20(a) of the Securities Exchange...
Nov 30, 2018 07:30 pm ET
Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of McKesson Corporation Investors (MCK)
Glancy Prongay & Murray LLP (“GPM”), a global investors rights law firm, announces that a class action lawsuit has been filed on behalf of investors that purchased or otherwise acquired McKesson Corporation (“McKesson” or the “Company”) (NYSE: 
Nov 30, 2018 05:32 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of McKesson Corporation - MCK
Pomerantz LLP is investigating claims on behalf of investors of McKesson Corporation (“McKesson” or the “Company”) (NYSE: MCK).   Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980. The...
Nov 30, 2018 04:15 pm ET
McKesson Announces New Global Headquarters in Las Colinas, Texas
McKesson Corporation (NYSE:MCK) today announced the relocation of its corporate headquarters from San Francisco, California to Las Colinas, Texas, effective April 1, 2019, expanding upon its presence in the Dallas area.
Nov 29, 2018 08:32 pm ET
Glancy Prongay & Murray LLP Announces Investigation on Behalf of McKesson Corporation Investors (MCK)
Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of McKesson Corporation(“McKesson” or the “Company”) (NYSE:
Nov 29, 2018 05:47 pm ET
MCK LOSS NOTICE: Rosen Law Firm Reminds McKesson Corporation Investors of Important Deadline in Class Action – MCK
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of McKesson Corporation (NYSE:MCK) from October 24, 2013 through January 25, 2017, inclusive (the “Class Period”) of the important December 26, 2018 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for McKesson investors under the federal securities laws.
Nov 29, 2018 10:00 am ET
SHAREHOLDER ALERT -- Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against McKesson Corporation (MCK) and Lead Plaintiff Deadline -December 26, 2018
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against McKesson Corporation (“McKesson” or the “Company”) (NYSE: MCK) on behalf of shareholders who purchased or otherwise...
Nov 28, 2018 07:58 pm ET
Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of McKesson Corporation Investors (MCK)
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors that purchased McKesson Corporation (“McKesson” or the “Company”) (NYSE: MCK) securities between October 24, 2013 and January 25, 2017 inclusive (the “Class Period”). McKesson investors have until December 26,
Nov 26, 2018 04:05 pm ET
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of McKesson Corporation Investors (MCK)
Law Offices of Howard G. Smith announces an investigation on behalf of McKesson Corporation (“McKesson” or the “Company”) (NYSE: MCK) investors concerning the Company and its officers’ possible violations of federal securities laws.
Nov 26, 2018 12:00 pm ET
INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against McKesson Corporation and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against McKesson Corporation (“McKesson” or “the Company”) (NYSE: MCK) for violations of §§10(b) and 20(a) of the Securities Exchange...
Nov 23, 2018 06:32 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of McKesson Corporation - MCK
Pomerantz LLP is investigating claims on behalf of investors of McKesson Corporation (“McKesson” or the “Company”) (NYSE: MCK). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980. The...
Nov 19, 2018 01:59 pm ET
INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against McKesson Corporation and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against McKesson Corporation (“McKesson” or “the Company”) (NYSE: MCK) for violations of §§10(b) and 20(a) of the Securities Exchange...
Nov 16, 2018 05:37 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of McKesson Corporation - MCK
Pomerantz LLP is investigating claims on behalf of investors of McKesson Corporation (“McKesson” or the “Company”) (NYSE: MCK).  Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980....
Nov 16, 2018 03:49 pm ET
IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against McKesson Corporation and Encourages Investors with Losses in Excess of $500,000 to Contact the F
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against McKesson Corporation (“McKesson” or “the Company”) (NYSE:
Nov 15, 2018 10:38 pm ET
IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against McKesson Corporation and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against McKesson Corporation (“McKesson” or “the Company”) (NYSE:
Nov 15, 2018 07:07 pm ET
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against McKesson Corporation – MCK
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of McKesson Corporation (NYSE:MCK) from October 24, 2013 through January 25, 2017, inclusive (the “Class Period”). The lawsuit seeks to recover damages for McKesson investors under the federal securities laws.
Nov 09, 2018 07:35 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of McKesson Corporation - MCK
Pomerantz LLP is investigating claims on behalf of investors of McKesson Corporation (“McKesson” or the “Company”) (NYSE: MCK).  Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980. The...
Nov 08, 2018 06:15 pm ET
CURRENT SHAREHOLDERS: Zamansky LLC Investigates McKesson (MCK) for Potential Breaches of Fiduciary Duties
Zamansky LLC announces that it is investigating McKesson Corporation (NYSE:MCK) (“McKesson” or the “Company”) for potential breaches of fiduciary duties by its senior officers and board of directors. If you are a shareholder of McKesson who still holds your shares, please contact our firm for information.
Nov 02, 2018 08:07 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of McKesson Corporation - MCK
Pomerantz LLP is investigating claims on behalf of investors of McKesson Corporation (“McKesson” or the “Company”) (NYSE:MCK). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980. The...
Nov 01, 2018 04:15 pm ET
John Hammergren Announces Retirement; Brian Tyler to Become McKesson’s CEO and Edward Mueller to Chair Board
McKesson Corporation (NYSE:MCK) today announced that John H. Hammergren, chairman and chief executive officer (CEO), has decided to retire, effective March 31, 2019. McKesson’s Board of Directors has unanimously selected Brian Tyler, 51, currently president and chief operating officer (COO), to succeed Hammergren as CEO, effective April 1, 2019. Tyler will also remain as president.
Oct 30, 2018 08:20 am ET
Research Report Identifies Deckers Outdoor, Navient, Phillips 66, BioMarin Pharmaceutical, McKesson, and Equity Residential with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Deckers Outdoor Corporation (NYSE:DECK), Navient Corporation...
Oct 29, 2018 07:46 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claim On Behalf of Investors of McKesson Corporation - MCK
Pomerantz LLP is investigating claims on behalf of investors of McKesson Corporation (“McKesson” or the “Company”) (NYSE: MCK).  Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980. The...
Oct 29, 2018 02:57 pm ET
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against McKesson Corporation (MCK) and Lead Plaintiff Deadline: December 26, 2018
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against McKesson Corporation (“McKesson” or the “Company”) (NYSE: MCK) on behalf of shareholders who purchased or otherwise...
Oct 26, 2018 10:35 am ET
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of McKesson Corporation (MCK)
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of McKesson Corporation (“McKesson” or the “Company”) (NYSE: MCK). Such investors are encouraged to obtain additional information...
Oct 26, 2018 08:05 am ET
Shareholder Alert - Bleichmar Fonti & Auld LLP Files Securities Class Action Lawsuit Against McKesson Corporation
Bleichmar Fonti & Auld LLP (“BFA”) announces that it has filed a class action lawsuit on behalf of a class (the “Class”) consisting of persons and entities that acquired McKesson Corporation (“McKesson” or the “Company”) (NYSE:MCK) common stock...
Oct 25, 2018 07:00 am ET
McKesson Reports Fiscal 2019 Second-Quarter Results
McKesson Corporation (NYSE:MCK) today reported that revenues for the second quarter ended September 30, 2018, were $53.1 billion, up 2% compared to $52.1 billion a year ago, and also up 2% on a constant currency basis. On the basis of U.S. generally accepted accounting principles (“GAAP”), second-quarter earnings per diluted share from continuing operations was $2.51, compared to earnings per diluted share of $0.01 a year ago. GAAP earnings per diluted share included a pre-tax benefit of $90 million, or $0.33 per diluted share, related to a
Oct 04, 2018 04:10 pm ET
McKesson Corporation Fiscal 2019 Second Quarter Conference Call Scheduled for October 25, 2018
McKesson Corporation (NYSE:MCK) will release financial results for its second fiscal quarter ended September 30, 2018 on Thursday, October 25, 2018, prior to the opening of trading on the New York Stock Exchange. The company has scheduled a conference call for 8:00 AM Eastern Time (5:00 AM Pacific Time), during which John Hammergren, chairman and chief executive officer, and Britt Vitalone, executive vice president and chief financial officer, will review these results.
Sep 13, 2018 04:10 pm ET
McKesson Board of Directors Elects Dominic Caruso as New Independent Director
McKesson Corporation (NYSE:MCK) today announced that its Board of Directors has elected Dominic Caruso as a new independent director, effective September 12, 2018. With the election of Dominic Caruso, McKesson’s Board of Directors increases from eight to nine members, eight of whom are independent.
Aug 23, 2018 04:10 pm ET
McKesson Corporation to Present at the Morgan Stanley Global Healthcare Conference
McKesson Corporation (NYSE:MCK) announced that Britt Vitalone, the company’s executive vice president and chief financial officer, will present at the Morgan Stanley Global Healthcare Conference in New York at 10:30 a.m. ET on Friday, September 14, 2018. Audio webcasts will be available live and archived on the company’s Investor Relations website at
Jul 31, 2018 09:00 am ET
McKesson Appoints Brian Tyler as President and Chief Operating Officer
McKesson Corporation (NYSE:MCK) today announced that Brian S. Tyler, Ph.D., has been appointed president and chief operating officer, McKesson Corporation, effective August 2, 2018. Tyler will report to John Hammergren, chairman and chief executive officer, and will become a member of the executive committee.
Jul 26, 2018 07:00 am ET
McKesson Reports Fiscal 2019 First-Quarter Results
McKesson Corporation (NYSE:MCK) today reported that revenues for the first quarter ended June 30, 2018, were $52.6 billion, up 3% compared to $51.1 billion a year ago. On a constant currency basis, revenues increased 2% over the prior year. On the basis of U.S. generally accepted accounting principles (“GAAP”), first-quarter loss per diluted share from continuing operations was $(0.69), compared to earnings per diluted share of $1.44 a year ago. GAAP loss per diluted share included a pre-tax and after-tax non-cash goodwill impairment charge of $
Jul 25, 2018 03:09 pm ET
McKesson Announces Preliminary Voting Results from 2018 Annual Meeting of Stockholders
McKesson Corporation (NYSE:MCK) today announced preliminary voting results from its Annual Meeting of Stockholders, held earlier today in Irving, Texas. All directors were re-elected, the non-binding advisory vote on executive compensation was approved, and all Board vote recommendations were supported.
Jul 05, 2018 04:10 pm ET
McKesson Corporation Fiscal 2019 First Quarter Conference Call Scheduled for July 26, 2018
McKesson Corporation (NYSE:MCK) will release financial results for its first fiscal quarter ended June 30, 2018 on Thursday, July 26, 2018, prior to the opening of trading on the New York Stock Exchange. The company has scheduled a conference call for 8:00 AM Eastern Time (5:00 AM Pacific Time), during which John Hammergren, chairman and chief executive officer, and Britt Vitalone, executive vice president and chief financial officer, will review these results.
Jun 28, 2018 09:00 am ET
McKesson Reaffirms Fiscal 2019 Guidance and Provides Preliminary Guidance for the First Quarter
McKesson Corporation (NYSE:MCK) today reaffirmed its Adjusted Earnings per diluted share guidance of $13.00 to $13.80 for the fiscal year ending March 31, 2019, and the underlying key assumptions provided in its press release on May 24, 2018. The company also anticipates Adjusted Earnings per diluted share of approximately $2.85 to $2.95 for the first quarter of Fiscal 2019.
Jun 27, 2018 07:45 am ET
Investor Expectations to Drive Momentum within CenterPoint Energy, Univar, NOW, McKesson, Brinker International, and TAL Education Group — Discovering Underlying Factors of Influence
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of CenterPoint Energy, Inc. (NYSE:CNP), Univar Inc. (NYSE:UNVR), NOW Inc....
Jun 12, 2018 09:00 am ET
Pharmapacks Raises $32.5 Million to Fund Expansion, Automation and Talent Acquisition
ISLANDIA, N.Y., June 12, 2018 /PRNewswire/ -- Pharmapacks, a leading e-commerce company with a proprietary technology platform that empowers brands to reach millions of consumers with a complete and cost-effective logistics, fulfillment, marketing and sales solution, today announced it has raised $32.5 million by selling a minority stake at an undisclosed valuation. The strategic round was led by multinational CPG company RB (LSE: RB) with additional investments from McKesson Ventures, Sealed Air (NYSE:SEE) and The Emerson Group. ...
Jun 01, 2018 09:10 am ET
McKesson Completes Acquisition of Medical Specialties Distributors
McKesson Corporation (NYSE:MCK), a global leader in healthcare supply chain management solutions, announced today that it has completed the previously announced acquisition of Medical Specialties Distributors.
May 29, 2018 04:10 pm ET
McKesson Corporation to Present at the Goldman Sachs 39th Annual Global Healthcare Conference and Host Investor Day
McKesson Corporation (NYSE:MCK) today announced that Britt Vitalone, executive vice president and chief financial officer, will present at the Goldman Sachs 39th Annual Global Healthcare Conference in Rancho Palos Verdes, CA at 2:00 p.m. PT on Wednesday, June 13, 2018.
May 24, 2018 07:00 am ET
McKesson Reports Fiscal 2018 Fourth-Quarter and Full-Year Results
McKesson Corporation (NYSE:MCK) today reported that revenues for the fourth quarter ended March 31, 2018, were $51.6 billion, up 6% compared to $48.7 billion a year ago. On a constant currency basis, revenues increased 4% over the prior year. For the fiscal year, McKesson had revenues of $208.4 billion, up 5% compared to $198.5 billion a year ago. On a constant currency basis, revenues increased 4% over the prior year.
May 11, 2018 08:25 am ET
Consolidated Research: 2018 Summary Expectations for STORE Capital, Microvision, International Game Technology, McKesson, Marinus Pharmaceuticals, and Alnylam Pharmaceuticals — Fundamental Analysis, K
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of STORE Capital Corporation (NYSE:STOR), Microvision, Inc. (NASDAQ:MVIS),...
Apr 30, 2018 09:02 am ET
McKesson Board of Directors Elects Brad Lerman as New Independent Director
McKesson Corporation (NYSE: MCK) today announced that its Board of Directors has elected Brad Lerman as a new independent director, effective April 24, 2018. With the election of Mr. Lerman, the size of McKesson’s Board of Directors increases from eight to nine members, eight of whom are independent.
Apr 30, 2018 09:00 am ET
McKesson Corporation Fiscal 2018 Fourth Quarter Conference Call Scheduled for May 24, 2018
McKesson Corporation (NYSE:MCK) will release financial results for its fourth fiscal quarter ended March 31, 2018 on Thursday, May 24, 2018, prior to the opening of trading on the New York Stock Exchange. The company has scheduled a conference call for 8:00 AM Eastern Time (5:00 AM Pacific Time), during which John Hammergren, chairman and chief executive officer, and Britt Vitalone, executive vice president and chief financial officer, will review these results.
Apr 25, 2018 04:10 pm ET
McKesson Launches Multi-Year Strategic Growth Initiative; Reaffirms Fiscal 2018 Outlook and Provides Preliminary Fiscal 2019 Outlook
McKesson Corporation (NYSE:MCK) today announced a multi-year strategic growth initiative, focused on creating innovative new solutions that improve patient care delivery and drive incremental profit growth. The initiative comprises multiple growth pillars, and includes a comprehensive review of the company’s operations and cost structure, designed to increase efficiency, accelerate execution and improve long-term performance.
Feb 22, 2018 04:10 pm ET
McKesson Corporation Announces Pricing of Tender Offer
McKesson Corporation (NYSE: MCK) (the “Company”) today announced the determination of the Full Tender Offer Consideration, as shown in the table below, for its previously announced cash tender offer to purchase up to $1,100,000,000 (the “Tender Cap”) combined aggregate purchase price (the “Offer”) of its outstanding 6.000% Notes due 2041 (the “6.000% Notes”), 7.650% Debentures due 2027 (the “7.650% Debentures”), 4.883% Notes due 2044 (the “4.883% Notes”), 4.750% Notes due 2021 (the “4.750% Notes”) and 7.500% Notes due 2019 (the “7.500% Notes” an
Feb 22, 2018 09:20 am ET
McKesson Corporation Announces Early Tender Results
McKesson Corporation (NYSE: MCK) (the “Company”) today announced the early tender results as of the Early Tender Time (as defined below) in connection with its previously announced cash tender offer to purchase up to $1,100,000,000 (the “Tender Cap”) combined aggregate purchase price (the “Offer”) of its outstanding 6.000% Notes due 2041 (the “6.000% Notes”), 7.650% Debentures due 2027 (the “7.650% Debentures”), 4.883% Notes due 2044 (the “4.883% Notes”), 4.750% Notes due 2021 (the “4.750% Notes”) and 7.500% Notes due 2019 (the “7.500% Notes” an
Feb 07, 2018 08:30 am ET
New Research Coverage Highlights Zions, McKesson, Sealed Air, CenterPoint Energy, Coca-Cola European Partners, and KKR & Co. — Consolidated Revenues, Company Growth, and Expectations for 2018
NEW YORK, Feb. 07, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Zions Bancorporation (NASDAQ:ZION), McKesson Corporation (NYSE:MCK),...
Feb 07, 2018 02:58 am ET
McKesson Corporation Announces Offer to Purchase Up to $1,100,000,000 Combined Purchase Price of Outstanding 6.000% Notes due 2041, 7.650% Debentures due 2027, 4.883% Notes due 2044, 4.750% Notes due
SAN FRANCISCO, Feb. 7, 2018 /PRNewswire/ -- McKesson Corporation (NYSE: MCK) (the "Company") today announced the commencement of a cash tender offer to purchase up to $1,100,000,000 (subject to increase, the "Tender Cap") combined aggregate purchase price (the "Offer") of its outstanding 6.000% Notes due 2041 (the "6.000% Notes"), 7.650% Debentures due 2027 (the "7.650% Debentures"), 4.883% Notes due 2044 (the "4.883% Notes"), 4.750% Notes due 2021 (the "4.750% Notes") and 7.500% Notes due 2019 (the "7.500% Notes" and together with the 6.000% Notes, the 7.650% Debentures, the 4.883% Notes...
Feb 01, 2018 07:00 am ET
McKesson Reports Fiscal 2018 Third-Quarter Results
McKesson Corporation (NYSE:MCK) today reported that revenues for the third quarter ended December 31, 2017, were $53.6 billion, up 7% compared to $50.1 billion a year ago. On the basis of U.S. generally accepted accounting principles (“GAAP”), third-quarter earnings per diluted share from continuing operations was $4.32, compared to $2.86 a year ago. Third-quarter GAAP earnings per diluted share included a net tax benefit of approximately $370 million, or $1.78, driven by the Tax Cuts and Jobs Act of 2017.
Jan 04, 2018 04:10 pm ET
McKesson Corporation Fiscal 2018 Third Quarter Conference Call Scheduled for February 1, 2018
McKesson Corporation (NYSE:MCK) will release financial results for its third fiscal quarter ended December 31, 2017 on Thursday, February 1, 2018, prior to the opening of trading on the New York Stock Exchange. The company has scheduled a conference call for 8:00 AM Eastern Time (5:00 AM Pacific Time), during which John Hammergren, chairman and chief executive officer, and Britt Vitalone, executive vice president and chief financial officer, will review these results.
Jan 03, 2018 09:00 am ET
McKesson Completes Acquisition of RxCrossroads
McKesson Corporation (NYSE:MCK), a global leader in healthcare supply chain management solutions, announced today that it has completed the previously announced acquisition of RxCrossroads.
Dec 19, 2017 04:10 pm ET
McKesson Corporation to Present at the 36th Annual J.P. Morgan Healthcare Conference
McKesson Corporation (NYSE:MCK) today announced that John Hammergren, chairman and chief executive officer, will present at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco at 8:30 a.m. PT on Tuesday, January 9, 2018. Audio webcasts will be available live and archived on the company’s Investor Relations website at
Dec 18, 2017 09:00 am ET
McKesson Announces Departure of James Beer, EVP and CFO; Appoints Internal Successor, Britt Vitalone; Reaffirms Fiscal 2018 Outlook
McKesson Corporation (NYSE:MCK) today announced James Beer, executive vice president and chief financial officer, will be leaving the company to pursue a new opportunity. Britt Vitalone, senior vice president and chief financial officer, U.S. Pharmaceutical and McKesson Specialty Health, will be appointed executive vice president and chief financial officer of McKesson, effective January 1, 2018. Beer will assist in a transition period into early 2018. In addition, today the company reaffirmed its outlook of Adjusted Earnings of $11.80 to $12.50
Nov 17, 2017 07:35 am ET
New Research Coverage Highlights Zions, McKesson, Sealed Air, CenterPoint Energy, Coca-Cola European Partners, and KKR & Co. — Consolidated Revenues, Company Growth, and Expectations for 2018
NEW YORK, Nov. 17, 2017 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Zions Bancorporation (NASDAQ:ZION), McKesson Corporation (NYSE:MCK),...
Nov 06, 2017 04:16 pm ET
McKesson Strengthens Its Portfolio of Manufacturer Solutions with the Acquisition of RxCrossroads
McKesson Corporation (NYSE:MCK) today announced that it has signed a definitive agreement to purchase RxCrossroads, a provider of tailored services to pharmaceutical and biotechnology manufacturers, from CVS Health Corporation (NYSE:CVS).
Oct 26, 2017 07:00 am ET
McKesson Reports Fiscal 2018 Second-Quarter Results
McKesson Corporation (NYSE:MCK) today reported that revenues for the second quarter ended September 30, 2017, were $52.1 billion, up 4% compared to $50.0 billion a year ago. On the basis of U.S. generally accepted accounting principles (“GAAP”), second-quarter earnings per diluted share from continuing operations was $0.01, compared to $1.35 a year ago. During the quarter, McKesson initiated a number of strategic and operational actions within our U.K. retail pharmacy business in response to the previously discussed U.K. government reimbursement
Oct 17, 2017 04:10 pm ET
McKesson Corporation to Present at the 26th Annual Credit Suisse Healthcare Conference
McKesson Corporation (NYSE:MCK) today announced that John Hammergren, chairman and chief executive officer, will present at the 26th Annual Credit Suisse Healthcare Conference in Scottsdale at 10:20 a.m. MST on Tuesday, November 7, 2017. Audio webcasts will be available live and archived on the company’s Investor Relations website at
Oct 05, 2017 04:10 pm ET
McKesson Corporation Fiscal 2018 Second Quarter Conference Call Scheduled for October 26, 2017
McKesson Corporation (NYSE:MCK) will release financial results for its second fiscal quarter ended September 30, 2017 on Thursday, October 26, 2017, prior to the opening of trading on the New York Stock Exchange. The company has scheduled a conference call for 8:00 AM Eastern Time (5:00 AM Pacific Time), during which John Hammergren, chairman and chief executive officer, and James Beer, executive vice president and chief financial officer, will review these results.
Aug 03, 2017 04:03 pm ET
Allscripts announces second quarter 2017 results
All-time record bookings total $407 million, 12 percent growth year-over-yearNew client business totals over one-third of bookings; revenue backlog at a record $4.1 billionRevenue $426 million, $428 million non-GAAP, growth of 10 and 8 percent respectively year-over-yearAllscripts to acquire hospital and health system business from McKesson Corporation CHICAGO, Aug. 03, 2017 (GLOBE NEWSWIRE) -- Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) (Allscripts) announced its financial results for the three and six months ended June 30, 2017....

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please subscribe. Our packages start at $1.00 plus tax for the first month.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.